![Alpha-synuclein stepwise aggregation reveals features of an early onset mutation in Parkinson's disease | Communications Biology Alpha-synuclein stepwise aggregation reveals features of an early onset mutation in Parkinson's disease | Communications Biology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs42003-019-0598-9/MediaObjects/42003_2019_598_Fig1_HTML.png)
Alpha-synuclein stepwise aggregation reveals features of an early onset mutation in Parkinson's disease | Communications Biology
![Sorting out release, uptake and processing of alpha‐synuclein during prion‐like spread of pathology - Tyson - 2016 - Journal of Neurochemistry - Wiley Online Library Sorting out release, uptake and processing of alpha‐synuclein during prion‐like spread of pathology - Tyson - 2016 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/42e39746-75ca-4336-98d2-0de89a429bf3/jnc13449-fig-0002-m.jpg)
Sorting out release, uptake and processing of alpha‐synuclein during prion‐like spread of pathology - Tyson - 2016 - Journal of Neurochemistry - Wiley Online Library
![Navigating the dynamic landscape of alpha-synuclein morphology: a review of the physiologically relevant tetrameric conformation Lucas HR, Fernández RD - Neural Regen Res Navigating the dynamic landscape of alpha-synuclein morphology: a review of the physiologically relevant tetrameric conformation Lucas HR, Fernández RD - Neural Regen Res](https://www.nrronline.org/articles/2020/15/3/images/NeuralRegenRes_2020_15_3_407_265792_f3.jpg)
Navigating the dynamic landscape of alpha-synuclein morphology: a review of the physiologically relevant tetrameric conformation Lucas HR, Fernández RD - Neural Regen Res
![CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson's disease | Nature Communications CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson's disease | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-020-18689-x/MediaObjects/41467_2020_18689_Fig1_HTML.png)
CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson's disease | Nature Communications
![CMT-3 targets different α-synuclein aggregates mitigating their toxic and inflammogenic effects | Scientific Reports CMT-3 targets different α-synuclein aggregates mitigating their toxic and inflammogenic effects | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-76927-0/MediaObjects/41598_2020_76927_Fig1_HTML.png)
CMT-3 targets different α-synuclein aggregates mitigating their toxic and inflammogenic effects | Scientific Reports
![Distinct α-synuclein strains can be defined by in vivo and in vitro... | Download Scientific Diagram Distinct α-synuclein strains can be defined by in vivo and in vitro... | Download Scientific Diagram](https://www.researchgate.net/publication/341563296/figure/fig3/AS:960110461472775@1605919580753/Distinct-a-synuclein-strains-can-be-defined-by-in-vivo-and-in-vitro-biological-activity.png)
Distinct α-synuclein strains can be defined by in vivo and in vitro... | Download Scientific Diagram
![A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity | PNAS A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity | PNAS](https://www.pnas.org/content/pnas/114/6/E1009/F10.large.jpg)
A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity | PNAS
![In vitro α-synuclein fibrils are amplified using PMCA. (a) A schematic... | Download Scientific Diagram In vitro α-synuclein fibrils are amplified using PMCA. (a) A schematic... | Download Scientific Diagram](https://www.researchgate.net/publication/315962661/figure/fig2/AS:482035308470277@1491937581666/n-vitro-a-synuclein-fibrils-are-amplified-using-PMCA-a-A-schematic-representation-of_Q640.jpg)
In vitro α-synuclein fibrils are amplified using PMCA. (a) A schematic... | Download Scientific Diagram
![Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics - Journal of Biological Chemistry Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics - Journal of Biological Chemistry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1064a536-36a0-4de2-8cef-b42cd8ad1c1a/gr1_lrg.jpg)
Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics - Journal of Biological Chemistry
![IJMS | Free Full-Text | Multiplicity of α-Synuclein Aggregated Species and Their Possible Roles in Disease | HTML IJMS | Free Full-Text | Multiplicity of α-Synuclein Aggregated Species and Their Possible Roles in Disease | HTML](https://www.mdpi.com/ijms/ijms-21-08043/article_deploy/html/images/ijms-21-08043-g001.png)